<DOC>
	<DOCNO>NCT00486291</DOCNO>
	<brief_summary>The purpose study evaluate efficacy safety VI-0521 compare placebo glycemic management obese diabetic adult .</brief_summary>
	<brief_title>Study VI-0521 Compared Placebo Glycemic Management Obese Diabetics</brief_title>
	<detailed_description />
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Diabetes Mellitus , Type 2</mesh_term>
	<criteria>Informed consent Type 2 Diabetes BMI 2742 Specified diet/exercise and/or diabetes medication BP &gt; 150/95 Stroke/MI/unstable cardiovascular disease within 6 month Clinically significant renal , hepatic , psychiatric disease Unstable thyroid disease replacement therapy Nephrolithiasis Obesity know genetic endocrine origin Participation formal weight loss program lifestyle intervention History glaucoma Pregnancy breastfeed Alcohol abuse Eating disorder Excluded medication</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>September 2012</verification_date>
	<keyword>Diabetes , Obese diabetic</keyword>
</DOC>